T34908
D-甲状腺素
99%
别名:
3,3′,5,5′-四碘代-D-甲状腺原氨酸, 3-[4-(4-羟基-3,5-二碘苯氧基)-3,5-二碘苯基]-D-丙氨酸
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C15H11I4NO4
化学文摘社编号:
分子量:
776.87
PubChem Substance ID:
UNSPSC Code:
12352101
Beilstein/REAXYS Number:
2954910
MDL number:
assay
99%
mp
~235 °C (dec.)
SMILES string
N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O
InChI
1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1
InChI key
XUIIKFGFIJCVMT-GFCCVEGCSA-N
Gene Information
human ... THRA(7067), THRB(7068)
法规信息
新产品
此项目有
Rational drug therapy of the hyperlipoproteinemias, Part II.
C B Blum et al.
Rational drug therapy, 20(10), 1-4 (1986-10-01)
R Narihara et al.
Neurochemistry international, 25(5), 451-454 (1994-11-01)
The effects of thyroxine and its related derivatives on gamma-aminobutyric acid (GABA) receptors in the rat brain were examined. D-Thyroxine strongly inhibited [3H]flunitrazepam binding to benzodiazepine receptor in crude synaptic membrane from the rat brain. The Scatchard analysis of the
R S Perry
Clinical pharmacy, 5(2), 113-127 (1986-02-01)
The biochemistry, etiology, and evaluation of hyperlipidemia and its management, including dietary and drug therapies, are discussed. Strong evidence supports the role of increased cholesterol concentrations as an independent risk factor for coronary artery disease (CAD); however, evidence that elevated